Strengthening laboratory capacity for HIV vaccine clinical trials and epidemiological studies in Eastern and Southern Africa [version 1; peer review: 2 approved with reservations]

Background: Conducting successful HIV vaccine clinical trials in resource-limited settings is hampered by lack of adequate laboratory capacity at trial sites, poor infrastructure, lack of well-trained technical personnel, and inadequate laboratory quality management Systems. We describe our approach...

Full description

Saved in:
Bibliographic Details
Published inF1000 research Vol. 11; p. 72
Main Authors Farah, Bashir, Maraka, Moureen, Mshai, Mercy, Chetty, Paramesh, Murungi, Linda, Ochiel, Daniel, Gilmour, Jill
Format Journal Article
LanguageEnglish
Published 2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background: Conducting successful HIV vaccine clinical trials in resource-limited settings is hampered by lack of adequate laboratory capacity at trial sites, poor infrastructure, lack of well-trained technical personnel, and inadequate laboratory quality management Systems. We describe our approach to establishing sustainable laboratory capacity for clinical trials in Africa. Methods: IAVI identified 9 CRCs where a capacity building program that supports immunology and clinical testing was established. Information from the 9 CRCs was collected retrospectively and compiled in Microsoft excel for descriptive statistics. Mapping was done in Quantum Geographic information system. Results: Newly built and refurbished laboratories have been equipped with the required testing laboratory equipment. All CRC laboratories (n=10, 100%) received Good Clinical Laboratory Practice (GCLP) accreditation between 2004 and 2016, and accreditation maintained annually. A total of 89 audits were done between 2005-2019. KAVI and KEMRI had the highest number of audits (n=11, 12.4%). IAVI successfully trained a total of 1811 individual, of which (n=1130, 62.7%) trained on GCLP, (n=330, 18.3%) Quality Management Systems, (n=311, 17,2%) laboratory techniques and (n=32,1.8%) between 2004 and 2021. All the 13 Assays were registered in either College of American pathologist (CAP) or Royal college of pathologists of Australasia (RCPA) for Proficiency testing. Conclusion: The establishment of GCLP accredited laboratories and well-trained personnel has created centers of excellence and it has enabled them to attract independent competitive research funding. The GCLP accreditation and standardized testing procedures ensured reliable and accurate data, especially important for multi-country and multi-center studies.
AbstractList Background: Conducting successful HIV vaccine clinical trials in resource-limited settings is hampered by lack of adequate laboratory capacity at trial sites, poor infrastructure, lack of well-trained technical personnel, and inadequate laboratory quality management Systems. We describe our approach to establishing sustainable laboratory capacity for clinical trials in Africa. Methods: IAVI identified 9 CRCs where a capacity building program that supports immunology and clinical testing was established. Information from the 9 CRCs was collected retrospectively and compiled in Microsoft excel for descriptive statistics. Mapping was done in Quantum Geographic information system. Results: Newly built and refurbished laboratories have been equipped with the required testing laboratory equipment. All CRC laboratories (n=10, 100%) received Good Clinical Laboratory Practice (GCLP) accreditation between 2004 and 2016, and accreditation maintained annually. A total of 89 audits were done between 2005-2019. KAVI and KEMRI had the highest number of audits (n=11, 12.4%). IAVI successfully trained a total of 1811 individual, of which (n=1130, 62.7%) trained on GCLP, (n=330, 18.3%) Quality Management Systems, (n=311, 17,2%) laboratory techniques and (n=32,1.8%) between 2004 and 2021. All the 13 Assays were registered in either College of American pathologist (CAP) or Royal college of pathologists of Australasia (RCPA) for Proficiency testing. Conclusion: The establishment of GCLP accredited laboratories and well-trained personnel has created centers of excellence and it has enabled them to attract independent competitive research funding. The GCLP accreditation and standardized testing procedures ensured reliable and accurate data, especially important for multi-country and multi-center studies.
Background: Conducting successful HIV vaccine clinical trials in resource-limited settings is hampered by lack of adequate laboratory capacity at trial sites, poor infrastructure, lack of well-trained technical personnel, and inadequate laboratory quality management Systems. We describe our approach to establishing sustainable laboratory capacity for clinical trials in Africa. Methods: IAVI identified 9 CRCs where a capacity building program that supports immunology and clinical testing was established. Information from the 9 CRCs was collected retrospectively and compiled in Microsoft excel for descriptive statistics. Mapping was done in Quantum Geographic information system. Results: Newly built and refurbished laboratories have been equipped with the required testing laboratory equipment. All CRC laboratories (n=10, 100%) received Good Clinical Laboratory Practice (GCLP) accreditation between 2004 and 2016, and accreditation maintained annually. A total of 89 audits were done between 2005-2019. KAVI and KEMRI had the highest number of audits (n=11, 12.4%). IAVI successfully trained a total of 1811 individual, of which (n=1130, 62.7%) trained on GCLP, (n=330, 18.3%) Quality Management Systems, (n=311, 17,2%) laboratory techniques and (n=32,1.8%) between 2004 and 2021. All the 13 Assays were registered in either College of American pathologist (CAP) or Royal college of pathologists of Australasia (RCPA) for Proficiency testing. Conclusion: The establishment of GCLP accredited laboratories and well-trained personnel has created centers of excellence and it has enabled them to attract independent competitive research funding. The GCLP accreditation and standardized testing procedures ensured reliable and accurate data, especially important for multi-country and multi-center studies.
Author Ochiel, Daniel
Maraka, Moureen
Mshai, Mercy
Gilmour, Jill
Chetty, Paramesh
Farah, Bashir
Murungi, Linda
Author_xml – sequence: 1
  givenname: Bashir
  orcidid: 0000-0002-2666-2243
  surname: Farah
  fullname: Farah, Bashir
  email: Bfarah@iavi.org
  organization: IAVI Global Headquarters, New York NY, USA
– sequence: 2
  givenname: Moureen
  surname: Maraka
  fullname: Maraka, Moureen
  organization: IAVI Global Headquarters, New York NY, USA
– sequence: 3
  givenname: Mercy
  surname: Mshai
  fullname: Mshai, Mercy
  organization: IAVI Global Headquarters, New York NY, USA
– sequence: 4
  givenname: Paramesh
  surname: Chetty
  fullname: Chetty, Paramesh
  organization: IAVI, Southern Africa regional office, Centurion, South Africa
– sequence: 5
  givenname: Linda
  surname: Murungi
  fullname: Murungi, Linda
  organization: IAVI Global Headquarters, New York NY, USA
– sequence: 6
  givenname: Daniel
  surname: Ochiel
  fullname: Ochiel, Daniel
  organization: IAVI Global Headquarters, New York NY, USA
– sequence: 7
  givenname: Jill
  surname: Gilmour
  fullname: Gilmour, Jill
  organization: IAVI Human Immunology Laboratory, Imperial College, London, UK
BookMark eNqFkN1OHDEMhaOKSqWUV6j8ArvEmdnMBq4QgoKE1At-blA1ymac3aAhGTnZQftcfcEOS1W1V72yLX_HRz6fxUFMkYT4inKOSi-XJx6llEyZLLvNvKmaajHHD-JQyVrPsJbq4K_-kzjO-XkSSGMqrZpD8fOuMMV12VAMcQ29XSW2JfEOnB2sC2UHPjFc3zzCaJ0LkcD1IQZneygcbJ_Bxg5oCB29hNSn9X6Vy7YLlCFEuLS5EMc9dpe2k9M0nHueOHgaiXNIEfAMBiIGpjHQ6ykosMPAaaQOXkPZwNuDPNoysfnHF_HRT8Z0_LseiYery_uL69nt9283F-e3M6dQ4wyl8thIqY3Txiiqte2UdmTNonarypqlkY0zXVVj5bXDDiWuar-QGpcr8rI6Evr9ruOUM5NvBw4vlnctynaffvtP-u0-_RYn4em70Fu37cvuDWr_UP8R_wK1h5L4
Cites_doi 10.1097/QAI.0000000000000038
10.1016/bs.acc.2019.01.006
10.1371/journal.pmed.1000067
10.1057/jphp.2011.57
10.1016/j.cmi.2017.05.007
10.1186/s12960-020-00521-8
10.1371/journal.pone.0013592
10.1309/AJCPH1SKQ1HNWGHF
10.1086/367702
10.1086/499363
10.1515/jomb-2017-0025
10.4049/jimmunol.174.1.449
10.1586/14760584.2013.855612
10.1515/cclm-2017-1179
10.1373/clinchem.2011.168641
10.4314/pamj.v10i0.72235
10.6084/m9.figshare.16817482.v1
ContentType Journal Article
Copyright Copyright: © 2022 Farah B et al.
Copyright_xml – notice: Copyright: © 2022 Farah B et al.
DBID C-E
CH4
AAYXX
CITATION
DOI 10.12688/f1000research.73735.1
DatabaseName F1000Research
Faculty of 1000
CrossRef
DatabaseTitle CrossRef
DatabaseTitleList CrossRef

DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Women's Studies
EISSN 2046-1402
ExternalDocumentID 10_12688_f1000research_73735_1
GrantInformation_xml – fundername: This study is made possible by the support of the American People through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through United States Agency for International Development (USAID); a full list of IAVI donors is available at www.iavi.org. The contents of this study are the sole responsibility of IAVI and do not necessarily reflect the views of PEPFAR, USAID, or the United States Government.
GroupedDBID 3V.
53G
5VS
7X7
88I
8FE
8FH
8FI
8FJ
AAFWJ
ABUWG
ACGOD
ACPRK
ADBBV
ADRAZ
AFKRA
AHMBA
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
C-E
CH4
DIK
DWQXO
FRP
FYUFA
GNUQQ
GROUPED_DOAJ
GX1
HCIFZ
HYE
KQ8
LK8
M2P
M48
M7P
M~E
OK1
PIMPY
PQEST
PQQKQ
PQUKI
PROAC
RPM
UKHRP
W2D
AAYXX
ALIPV
CCPQU
CITATION
HMCUK
PGMZT
ID FETCH-LOGICAL-c2161-102f170069c6992e46ad26cea954cb3a98907c9d3413f6c1d101b4f50618bef03
IEDL.DBID M48
ISSN 2046-1402
IngestDate Fri Nov 22 00:22:30 EST 2024
Fri Feb 10 01:10:34 EST 2023
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords Clinical
GCLP
Strengthening
Accreditation
Capacity
Language English
License http://creativecommons.org/licenses/by/4.0/: This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c2161-102f170069c6992e46ad26cea954cb3a98907c9d3413f6c1d101b4f50618bef03
ORCID 0000-0002-2666-2243
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.12688/f1000research.73735.1
ParticipantIDs crossref_primary_10_12688_f1000research_73735_1
faculty1000_research_10_12688_f1000research_73735_1
PublicationCentury 2000
PublicationDate 2022
2022-00-00
PublicationDateYYYYMMDD 2022-01-01
PublicationDate_xml – year: 2022
  text: 2022
PublicationDecade 2020
PublicationTitle F1000 research
PublicationYear 2022
References T Crucitti (ref4) 2010; 5
J Pum (ref23) 2019; 90
P Fonjungo (ref24) 2012 Feb 10 cited 2019 May 10; 33
M Sarzotti-kelsoe (ref7) 2009; 6
W Miller (ref12) 2011; 57
S Kim Ong (ref15) 2020; 18
J Fitzgibbon (ref3) 2014 Jan 1 cited 2019 May 10; 65
P Nsubuga (ref14) 2011; 10
L Sciacovelli (ref20) 2018 Oct 1 cited 2021 Jul 12; 56
(ref10) 2019 cited 2019 May 10
T Zima (ref19) 2017 Sep 1 cited 2021 Jul 12; 36
S Kochhar (ref2) 2013; 12
T Stiles (ref6) 2012
B Barbé (ref16) 2017; 23
(ref9) cited 2021 Jun 4
(ref17) 2009
B Farah (ref25)
T Peter (ref18) 2010; 134
(ref1) 2018 cited 2019 May 10
N Russell (ref22) 2003; 187
C Petti (ref5) 2006; 42
J Vuola (ref21) 2005 Jan 1 cited 2019 May 10; 174
References_xml – volume: 65
  start-page: S36-S39
  year: 2014 Jan 1 cited 2019 May 10
  ident: ref3
  article-title: Laboratory challenges conducting international clinical research in resource-limited settings.
  publication-title: J. Acquir. Immune Defic. Syndr.
  doi: 10.1097/QAI.0000000000000038
  contributor:
    fullname: J Fitzgibbon
– volume: 90
  start-page: 215-281
  year: 2019
  ident: ref23
  article-title: A practical guide to validation and verification of analytical methods in the clinical laboratory.
  publication-title: Adv. Clin. Chem.
  doi: 10.1016/bs.acc.2019.01.006
  contributor:
    fullname: J Pum
– volume: 6
  start-page: 1-5
  year: 2009
  ident: ref7
  article-title: Evaluation and Recommendations on Good Clinical Laboratory Practice Guidelines for Phase I – III Clinical Trials.
  publication-title: PLoS Med.
  doi: 10.1371/journal.pmed.1000067
  contributor:
    fullname: M Sarzotti-kelsoe
– volume: 33
  start-page: 34-45
  year: 2012 Feb 10 cited 2019 May 10
  ident: ref24
  article-title: Laboratory equipment maintenance: a critical bottleneck for strengthening health systems in sub-Saharan Africa?.
  publication-title: J. Public Health Policy.
  doi: 10.1057/jphp.2011.57
  contributor:
    fullname: P Fonjungo
– year: 2018 cited 2019 May 10
  ident: ref1
  article-title: UNAIDS DATA 2018.
– volume: 23
  start-page: 426-433
  year: 2017
  ident: ref16
  article-title: Implementation of quality management for clinical bacteriology in low-resource settings.
  publication-title: Clin. Microbiol. Infect.
  doi: 10.1016/j.cmi.2017.05.007
  contributor:
    fullname: B Barbé
– volume: 18
  start-page: 84
  year: 2020
  ident: ref15
  article-title: Strengthening the clinical laboratory workforce in Cambodia: a case study of a mixed-method in-service training program to improve laboratory quality management system oversight.
  publication-title: Hum. Resour. Heal.
  doi: 10.1186/s12960-020-00521-8
  contributor:
    fullname: S Kim Ong
– volume: 5
  start-page: 1-8
  year: 2010
  ident: ref4
  article-title: Obtaining Valid Laboratory Data in Clinical Trials Conducted in Resource Diverse Settings: Lessons Learned from a Microbicide Phase III Clinical Trial.
  publication-title: PLoS One.
  doi: 10.1371/journal.pone.0013592
  contributor:
    fullname: T Crucitti
– start-page: 1-28
  year: 2012
  ident: ref6
  article-title: Good Clinical Laboratory Practice clinical trials.
  publication-title: Research Quality Association (RQA).
  contributor:
    fullname: T Stiles
– year: cited 2021 Jun 4
  ident: ref9
  article-title: Qualogy - Regulatory Archiving Services and Consultancy.
– start-page: 6-22
  year: 2009
  ident: ref17
  article-title: Good Clinical Laboratory Guideline.
– volume: 134
  start-page: 550-555
  year: 2010
  ident: ref18
  article-title: Impact of laboratory accreditation on patient care and the health system.
  publication-title: American Journal of Clinical Pathology. American Society of Clinical Pathologists.
  doi: 10.1309/AJCPH1SKQ1HNWGHF
  contributor:
    fullname: T Peter
– volume: 187
  start-page: 226-242
  year: 2003
  ident: ref22
  article-title: Moving to Human Immunodeficiency Virus Type 1 Vaccine Efficacy Trials: Defining T Cell Responses As Potential Correlates of Immunity.
  publication-title: J. Infect. Dis.
  doi: 10.1086/367702
  contributor:
    fullname: N Russell
– volume: 42
  start-page: 377-382
  year: 2006
  ident: ref5
  article-title: Laboratory Medicine in Africa: A Barrier to Effective Health Care.
  publication-title: Clin. Infect. Dis.
  doi: 10.1086/499363
  contributor:
    fullname: C Petti
– volume: 36
  start-page: 231-237
  year: 2017 Sep 1 cited 2021 Jul 12
  ident: ref19
  article-title: Accreditation of Medical Laboratories – System, Process, Benefits for Labs.
  publication-title: J. Med. Biochem.
  doi: 10.1515/jomb-2017-0025
  contributor:
    fullname: T Zima
– volume: 174
  start-page: 449-455
  year: 2005 Jan 1 cited 2019 May 10
  ident: ref21
  article-title: Differential immunogenicity of various heterologous prime-boost vaccine regimens using DNA and viral vectors in healthy volunteers.
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.174.1.449
  contributor:
    fullname: J Vuola
– volume: 12
  start-page: 1465-1478
  year: 2013
  ident: ref2
  article-title: Introducing new vaccines in developing countries.
  publication-title: Expert Rev. Vaccines.
  doi: 10.1586/14760584.2013.855612
  contributor:
    fullname: S Kochhar
– year: 2019 cited 2019 May 10
  ident: ref10
  article-title: 404 - Wits University.
– volume: 56
  start-page: 1644-1654
  year: 2018 Oct 1 cited 2021 Jul 12
  ident: ref20
  article-title: External quality assessment programs in the context of ISO 15189 accreditation.
  publication-title: Clin. Chem. Lab. Med.
  doi: 10.1515/cclm-2017-1179
  contributor:
    fullname: L Sciacovelli
– volume: 57
  start-page: 1670-1680
  year: 2011
  ident: ref12
  article-title: Proficiency Testing/External Quality Assessment: Current Challenges and Future Directions CONTENT.
  publication-title: Clin. Chem.
  doi: 10.1373/clinchem.2011.168641
  contributor:
    fullname: W Miller
– volume: 10
  start-page: 0-12
  year: 2011
  ident: ref14
  article-title: Field epidemiology and laboratory training programs in sub-saharan Africa from 2004 to 2010: Need, the process, and prospects.
  publication-title: Pan Afr. Med. J.
  doi: 10.4314/pamj.v10i0.72235
  contributor:
    fullname: P Nsubuga
– ident: ref25
  article-title: GCLP Audits and Training Raw Data, Figshare.
  doi: 10.6084/m9.figshare.16817482.v1
  contributor:
    fullname: B Farah
SSID ssj0000993627
Score 2.2570484
Snippet Background: Conducting successful HIV vaccine clinical trials in resource-limited settings is hampered by lack of adequate laboratory capacity at trial sites,...
Background: Conducting successful HIV vaccine clinical trials in resource-limited settings is hampered by lack of adequate laboratory capacity at trial sites,...
SourceID crossref
faculty1000
SourceType Aggregation Database
Publisher
StartPage 72
Title Strengthening laboratory capacity for HIV vaccine clinical trials and epidemiological studies in Eastern and Southern Africa [version 1; peer review: 2 approved with reservations]
URI http://dx.doi.org/10.12688/f1000research.73735.1
Volume 11
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bS8MwFA5DQfRh6FScl5EHwafONm3T5kFEZHMK88nJ3kqapl6QTtcpDvzxnpNmuoEMfCmUXAo5Tc73JSffIeSYpW4kcq0drt3YCTItHQD1GOygODqcSGQmQPaW9wbBzTAc1sgsXaodwPJPaof5pAbjl_bn2_QcJvyZ0UbgwOBy3KS24jiP7ciP_LANjGiVgXfEMK--hfzPFSKCNRtvUTOgho5nAnxay7ta8FkbuURRjClWnHNF3U1StxiSXlRG3yI1XTTIWt-ekjdI3aSlPCmpDRLcJl94-Fw8oNIBuCpqLT8aT6kCZ6kAiVMAr7R3fU8_pMJe6OzKJDV5PUoqi4zq33Sypqis-qdPBe1Io7hgqpm0fPhSJSHaIYNu5-6y59i8C45iAABhZWY5yvZxobgQTAdcZowrLUUYqNSXIgZGrUSGDjDnystgWqdBHgI0iFOdu_4uWSlGhd4jlAFhEn4QBxImoxZcuqEMhUJRGBcaiiY5nY1s8lrJayRIS9AWyYItEmOLxGsSf84AyU_x8lb7__7OAVlneNPB7LYckpXJ-F0fAf6YpC3D2-F5NfRa5uf6BnRe14E
link.rule.ids 314,780,784,864,4024,24318,27923,27924,27925
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Strengthening+laboratory+capacity+for+HIV+vaccine+clinical+trials+and+epidemiological+studies+in+Eastern+and+Southern+Africa&rft.jtitle=F1000+research&rft.au=Farah%2C+Bashir&rft.au=Maraka%2C+Moureen&rft.au=Mshai%2C+Mercy&rft.au=Chetty%2C+Paramesh&rft.date=2022&rft.issn=2046-1402&rft.eissn=2046-1402&rft.volume=11&rft.spage=72&rft_id=info:doi/10.12688%2Ff1000research.73735.1&rft.externalDBID=n%2Fa&rft.externalDocID=10_12688_f1000research_73735_1
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2046-1402&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2046-1402&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2046-1402&client=summon